From Botanicals
to FDA-Approved Drugs

Our pioneering work with leading research partners has led to the identification of more than 500 compounds in our proprietary hemp extract. While developing unique cultivars and wholly owning the supply chain and processing techniques that ensure consistent, efficacious botanical extracts, Cultivate Biologics developed a unique blueprint for bringing certainty to botanical-based drugs, with a current focus on hemp.

Over the last 12 years, Cultivate has bred hemp genetics that are high in CBDA, unique flavonoids, and terpenes. Our process includes genetic fingerprinting of our cultivars, characterizing the chemical composition of extracts, proving reproducibility and manufacturing at pharmaceutical standards.